| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Poliovirus (Types 1, 3) Antibodies, Neutralization
Test CodePLO13
Alias/See Also
LAB12943
CPT Codes
<p>86382 (x2)</p>
Preferred Specimen
Specimen Type: Serum
Collection Container/Type
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Minimum Volume
0.5 mL
Transport Container
Plastic screw-cap vial
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 5 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
Culture/Neutralization
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon, Thurs a.m.; Report available: 2-7 days
Report Available
2-7 days
Reference Range
| Polio 1 Titer | <1:8 titer |
| Polio 3 Titer | <1:8 titer |
Clinical Significance
This sensitive procedure is recommended for vaccine response testing and type-specific serodiagnosis of recent poliovirus infection. It can also serve as an aid for diagnosing immune deficiency disorders.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA
33608 Ortega Highway
San Juan Capistrano, CA 92675-2042
Last Updated: February 17, 2023